Apimeds - Prakiraan wutah bathi resik saben saham kanggo taun ngarep APUS

Apimeds Pharmaceuticals (APUS) relies on unique patents for bee venom toxin purification to combat pain. This chart on GURU.Markets shows that the target net income per share growth reflects current dynamics, where 0.00 becomes the new value of the indicator. The company plans to capture the market through the expansion of biologics, with final FDA trial stages serving as the growth catalyst.

Apimeds (APUS): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 10.05.2025 nganti 14.11.2026

Ringkesan rincian data analitis Apimeds Pharmaceuticals US (APUS)

- rega lan prakiraan konsensus rega:

Bagan rega Apimeds Pharmaceuticals, Inc.|APUS - Konsensus nilai wajar

- rincian nilai pasar emiten:

Nilai pasar Apimeds Pharmaceuticals|APUS - Total Nilai Perusahaan

- rincian nilai buku perusahaan:

Aset Bersih saben Siji Saham Apimeds Pharmaceuticals|APUS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku apimedsus.com|APUS - Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Total Utang marang Modal Apimeds Pharmaceuticals|APUS - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Apimeds Pharmaceuticals, Inc.|APUS - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Apimeds Pharmaceuticals|APUS - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Apimeds Pharmaceuticals|Rasio cepet apimedsus.com

- data bathi resik lan rasio valuasi:

APUS - Asil keuangan resik|Bathi sing dikarepake Apimeds Pharmaceuticals|APUS - Koefisien rega marang bathi|Pangali Forward P/E Apimeds Pharmaceuticals, Inc.|APUS - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Apimeds Pharmaceuticals|APUS - Bathi operasional sadurunge amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Apimeds Pharmaceuticals|APUS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan apimedsus.com|APUS - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Apimeds Pharmaceuticals

- statistik dodolan lan pendapatan perusahaan:

APUS - Pendapatan tahunan perusahaan|Prakiraan volume dodolan Apimeds Pharmaceuticals, Inc.|APUS - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Apimeds Pharmaceuticals

Analisis fundamental perusahaan:Apimeds Pharmaceuticals, APUS

Investors utilize this indicator to determine capitalization potential and business resilience through a consolidated EPS forecast. The development of innovative bee venom-based treatments for arthritis directly impacts this valuation of future earnings per share growth for Apimeds Pharmaceuticals (APUS). The positive trend in this metric confirms market confidence in the therapy's commercial success, shifting the asset into the category of high-yield speculative securities.

Pesaing utama